Xgeva 120 MG/1.7 ML vial 1.7ML
Ended Awarded
- Contract number
- SPE2DB25FBGY2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,656
Award facts
- Contract value 100% obligated
- $42,655.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of XGEVA 120 mg/1.7 mL vials with a ceiling value of $42,655.59 under a firm fixed-price contract. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania.
XGEVA (denosumab) is an oncology medication used to prevent skeletal-related events in patients with bone metastases, making this delivery order part of the Defense Health Agency's pharmaceutical supply chain supporting military medical facilities. AmerisourceBergen, as a major pharmaceutical distributor and critical federal medical procurement vendor, maintains an extensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains. The company's SPE2DX contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling supply to military healthcare programs worldwide, with anticipated expansion through the DLA Troop Support Pharmaceutical Prime Vendor Global Program Generation V initiative involving multiple regional awards.
Quick answers
Who was awarded contract SPE2DB25FBGY2?
SPE2DB25FBGY2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FBGY2 worth?
The government has obligated $42,656 on SPE2DB25FBGY2.
Is contract SPE2DB25FBGY2 an order under another contract?
Yes. SPE2DB25FBGY2 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FBGY2 competed?
The extent of competition for SPE2DB25FBGY2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award